Q32 Bio (QTTB) Revenue (2018 - 2023)

Q32 Bio's Revenue history runs 6 years deep, the most recent figure standing at -$1.4 million for Q4 2023.

• In Q4 2023, Revenue fell 269.58% year-over-year to -$1.4 million; the TTM figure through Sep 2024 stood at -$1.4 million (down 115.43% YoY), while the FY2025 annual figure was $53.7 million, changed N/A from the prior year.
• Revenue was -$1.4 million for Q4 2023 at Q32 Bio, down from $1.9 million in the prior quarter.
• In the past five years, Revenue ranged from a high of $29.3 million in Q1 2021 to a low of -$1.4 million in Q4 2023.
• Historically, Revenue has averaged $2.4 million across 5 years, with a median of $802000.0 in 2021.
• The sharpest annual moves came in 2021 and 2023: Revenue jumped 4883.84% in 2021, then slumped 269.58% in 2023.
• A 5-year view of Revenue shows it stood at $563000.0 in 2019, then soared by 74.07% to $980000.0 in 2020, then dropped by 18.16% to $802000.0 in 2021, then changed by 0.0% to $802000.0 in 2022, then plunged by 269.58% to -$1.4 million in 2023.
• The last three Revenue figures came in at -$1.4 million (Q4 2023), $1.9 million (Q3 2023), and $3.2 million (Q2 2023), per Business Quant data.